The independent reference for AI in cardiovascular medicine

Find, judge and use AI tools in cardiovascular medicine with confidence.

Evidence-graded, physician-reviewed information for the people who choose, teach, study, buy and build cardiovascular AI.

1,614 AI-enabled devices on the FDA list; 154 under the Cardiovascular panel. See the numbers

Newest in the Registry

EchoNext

Pathwai, Inc. · 510(k) · K260332²

EchoNext is intended to be used in parallel to the standard of care to analyze recordings of 12-lead ECG (electrocardiogram) made on compatible ECG devices.¹

Open in the Registry

Join the waitlist

For health systems

Technology assessment, governance and implementation strategy for cardiovascular service lines.

For training programs

Curriculum and resources for teaching AI competency, from medical school through fellowship.

For startups

Credible clinical evaluation sites and study design support for companies developing cardiology AI.

Five pillars, one engine

AI Tool Registry: We are building a searchable directory of every regulator-authorized cardiovascular AI product, with a standard profile and evidence grade.
Care Pathway Atlas: A condition-by-condition map of where AI fits in the patient journey, from detection to long-term follow-up.
Education Hub: Will offer a competency framework, adoptable curricula, a resource library and, later, accredited CME.
Research Methods Hub: A practical guide to AI study design, datasets, reporting standards, validation and regulatory pathways.
Entrepreneur Hub: Matches companies developing cardiology AI with hospitals and practices willing to evaluate tools.

All five run on the Intelligence Engine, an AI pipeline that monitors regulators, literature, trials, payers and societies, and routes every item to a physician editor before publication.